oxycodone + naloxone

BNF:
4.7.2
Status:
Do Not Prescribe (DNP)
Decision Date:
None
 

Comments

brands include Targinact, Myloxifin (updated October 2023)

Do Not Prescribe (DNP) Drug Classifications

  • 1: Are classified by the BNF as 'less suitable for prescribing', and includes anti-malarials (where a private prescription may be provided). Have a lack of data on effectiveness compared with standard therapy
  • 2: Have a lack of data on safety compared with standard therapy
  • 4: Have a lack of data on cost-effectiveness compared with standard therapy

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app